Arkolith/Insider Trading/EKSO/Form 4

Sherman Steven

CEO & Chairman, DirectorEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Jun 17, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2022Sell(S)7K$1.90$13K649K
Jun 10, 2021Grant(A)18K—$0656K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001549084-22-000035) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML